What this Trial Is About

Researchers are studying the prevalence of Central Sensitisation Syndrome (CSS) in women with endometriosis, a condition where endometrial cells grow outside the uterus causing symptoms like chronic pelvic pain and other related discomforts. The study aims to better understand how CSS, characterized by hypersensitivity to pain and other symptoms like fatigue and depression, relates to endometriosis. CSS is identified using the Central Sensitisation Inventory (CSI), a questionnaire assessing 25 clinical symptoms to diagnose this pain syndrome. Participants are women aged 18 to 50 with a clinical, ultrasound, or surgical diagnosis of endometriosis, who may be starting or already on hormone therapy. The study involves collecting information during gynecological exams and transvaginal ultrasound check-ups, with participants completing the CSI questionnaire during their visit. There are no additional treatments or interventions as this is an observational study. During the study, women will undergo their usual gynecological and ultrasound evaluations while completing the CSI questionnaire to assess symptoms of CSS. Researchers will measure how common CSS is among these women at their first visit after enrollment. The study also collects data on related risk factors and tracks participants' hormone therapy compliance and medical history. Safety and adherence to the study are monitored through these evaluations.

Central Awareness in Women With Endometriosis